WhiteRock Capital Partners Overview

  • Year Founded
  • 2004

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 50

Employees

  • Latest Deal Type
  • M&A

  • Financing Rounds
  • 1

  • Investments
  • 4

WhiteRock Capital Partners General Information

Description

Provider of strategic M&A and capital raising advisory services catering to small and middle-market companies. The company provides financial advisory, sell-side and buy-side advisory, restructuring, structured finance, equity financing, and leveraged and project finance services.

Contact Information

Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Corporate Backed or Acquired
Primary Industry
Investment Banks
Other Industries
Other Capital Markets/Institutions
Parent Company
Taiwan Shop
Corporate Office
  • 1350 Avenue of the Americas
  • 2nd Floor
  • New York, NY 10019
  • United States
+1 (646) 000-0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

WhiteRock Capital Partners Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore WhiteRock Capital Partners‘s full profile, request access.

Request a free trial

WhiteRock Capital Partners Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

WhiteRock Capital Partners Investments (4)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
BioTheryx 21-May-2021 00000 0000 0000 Drug Discovery
Renovion 29-May-2020 00000 0000 00.00 Drug Discovery
AveXis 03-Sep-2015 00000 0000 000.00 Drug Discovery
Agilis Biotherapeutics 24-Dec-2013 Early Stage VC 000 Biotechnology
To view WhiteRock Capital Partners’s complete investments history, request access »

WhiteRock Capital Partners Exits (2)

Company Name Exit Date Exit Type Exit Size Status Buyers
AveXis 03-Sep-2015 00000 00000 00 000.00 Completed
  • 16 buyers
Agilis Biotherapeutics 24-Dec-2013 Early Stage VC 000 Completed
  • 4 buyers
To view WhiteRock Capital Partners’s complete exits history, request access »

WhiteRock Capital Partners FAQs

  • When was WhiteRock Capital Partners founded?

    WhiteRock Capital Partners was founded in 2004.

  • Who is the founder of WhiteRock Capital Partners?

    Gustavo Dolfino is the founder of WhiteRock Capital Partners.

  • Where is WhiteRock Capital Partners headquartered?

    WhiteRock Capital Partners is headquartered in New York, NY.

  • What is the size of WhiteRock Capital Partners?

    WhiteRock Capital Partners has 50 total employees.

  • What industry is WhiteRock Capital Partners in?

    WhiteRock Capital Partners’s primary industry is Investment Banks.

  • Is WhiteRock Capital Partners a private or public company?

    WhiteRock Capital Partners is a Private company.

  • What is the current valuation of WhiteRock Capital Partners?

    The current valuation of WhiteRock Capital Partners is 0000.

  • What is WhiteRock Capital Partners’s current revenue?

    The current revenue for WhiteRock Capital Partners is 000000.

  • When was WhiteRock Capital Partners acquired?

    WhiteRock Capital Partners was acquired on 06-Mar-2015.

  • Who acquired WhiteRock Capital Partners?

    WhiteRock Capital Partners was acquired by Taiwan Shop.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »